Dividend Growth Rates History
| Year | Payout Amount | Annual Payout Growth (YoY) |
|---|---|---|
| 2019 | 2.140 | -% |
| 2018 | 3.590 | 40.2% |
| 2017 | 2.560 | 12.3% |
| 2016 | 2.280 | 12.9% |
| 2015 | 2.020 | 21.7% |
| 2014 | 1.660 | 3.8% |
| 2013 | 1.600 | 0.0% |
AbbVie Inc. (ABBV)
Exchange: New York Stock Exchange
Price: 72.99 (Close)
Summary
| 52 Week range | 200d Moving Avg. | Beta |
| 65.05 – 100.23 | 83.08 | 0.93 |
| Dividend | Dividend Yield | Ex-Dividend date |
| 4.06 | 5.56% | 2019-07-12 |
| P/E Ratio | Latest EPS | Latest EPS Date |
| 20.91 | 3.68 | 2018-12-31 |
 |
Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson’s disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.
| Sector: | Industry: |
| Health Technology | Pharmaceuticals: Major |
AbbVie Inc. (ABBV) Performance
The chart below displays the performance (%) of AbbVie Inc. for different periods:
Dividend Scorecard
| Dividend Yield (TTM) | Annual Payout | Payout Ratio | Dividend growth |
| 5.56 | 4.06 | 110.33% | 5 Years |
AbbVie Inc. (ABBV) Dividend Payment History
